Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0F4MI
|
||||
Former ID |
DIB013836
|
||||
Drug Name |
TAK-075
|
||||
Synonyms |
TAK-075; Calcium-sensing receptor antagonists (osteoporosis); Calcium-sensing receptor antagonists (osteoporosis), Takeda
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Osteoporosis [ICD9: 733.0, V07.4; ICD10:M80-M81, Z79.890] | Investigative | [543874] | ||
Company |
Takeda Pharmaceutical Co Ltd
|
||||
Structure |
Download2D MOL |
||||
Formula |
C36H46N4O4S
|
||||
Canonical SMILES |
C(C(CC)(NC(=O)c1c(nn2C(C)(C)C[C@@H](Nc12)c1ccccc1)C)c1c<br />cc(cc1)CC)C.S(=O)(=O)(c1ccc(cc1)C)O
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Extracellular calcium-sensing receptor | Target Info | Antagonist | [543874] | |
Pathway Interaction Database | E-cadherin signaling in keratinocytes | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.